Advances in reducing cardiovascular risk in the management of patients with type 2 diabetes mellitus

Treatment intended to lower cardiovascular (CV) risk in patients with diabetes has always been a primary goal of diabetes treatment. Due to the subdued effects of reducing hemoglobin A1c (HbA1c) on macrovascular complications, controlling other CV risk factors such as hypertension and hyperlipidemia...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Ying Hu
Formato: article
Lenguaje:EN
Publicado: KeAi Communications Co., Ltd. 2019
Materias:
Acceso en línea:https://doaj.org/article/629f46516f7f4dd2a8f15300457c6d7d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares